Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Biomax-Forte
- Development stage
- Unknown
- Lead developer
- Bioelite Lifesciences
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Biomax-Forte is a multi-ingredient therapeutic supplement developed and marketed by BioElite Life Sciences, specifically formulated for the management of bone health. It typically combines coral calcium (a source of calcium carbonate) with calcitriol (the active form of vitamin D3) and essential minerals including zinc and magnesium. Calcitriol acts as an agonist at the vitamin D receptor (VDR), significantly increasing the intestinal absorption of calcium and phosphate, while the calcium component provides the necessary substrate for bone mineralization. Zinc and magnesium serve as essential cofactors for alkaline phosphatase activity and hydroxyapatite crystal formation. Biomax-Forte is primarily indicated for the treatment and prevention of osteoporosis, osteomalacia, and other conditions characterized by low bone mineral density or calcium deficiency, often serving as a foundational therapy alongside specialized bone-acting agents like teriparatide or denosumab.
- Brand names
- Biomax-Forte
02
Targets
VDR (Vitamin D receptor)
Beyond the preview
Go deeper on Biomax-Forte.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biomax-Forte.